BG vs MRK · P/E 31, rev $23.76B vs P/E 33, rev $16.61B
Bunge Global SA (BG) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Bunge Global SA (BG) is a farm products company listed on NYSE.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported BG revenue for 2025-12-31 was $23.76B. Net income was $95.0M. Revenue was up 75.5% from 2024-12-31 to 2025-12-31. BG currently screens at market cap $22.53B and trailing P/E 30.6.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
BG currently screens at market cap $22.53B and trailing P/E 30.6. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the BG and MRK stock pages for the full models.
Not investment advice.